02/19/2025
3:05 PM | Arcus Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/18/2025
5:44 AM | Arcus Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/11/2025
8:10 PM | Arcus Biosciences (Issuer)
Markus Richard (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/11/2025
8:10 PM | Arcus Biosciences (Issuer)
Markus Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
4:02 PM | Arcus Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/27/2025
3:29 PM | Arcus Biosciences (Issuer)
Jaen Juan C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:30 PM | Arcus Biosciences (Issuer)
Lacey David L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:30 PM | Arcus Biosciences (Issuer)
Azoy Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:30 PM | Arcus Biosciences (Issuer)
Goeltz II Robert C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:30 PM | Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:30 PM | Arcus Biosciences (Issuer)
Ribas Antoni (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for RCUS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Arcus Biosciences and its competitors with MarketBeat's FREE daily newsletter. |
01/27/2025
3:30 PM | Arcus Biosciences (Issuer)
ROSEN TERRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:31 PM | Arcus Biosciences (Issuer)
Tang Carolyn C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:10 PM | Arcus Biosciences (Subject)
Goeltz II Robert C. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/17/2024
8:52 PM | Arcus Biosciences (Subject)
ROSEN TERRY J (Filed by)
| Form SC 13D/A | |
12/17/2024
7:35 PM | Arcus Biosciences (Issuer)
Jaen Juan C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:36 PM | Arcus Biosciences (Issuer)
Azoy Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:36 PM | Arcus Biosciences (Issuer)
Goeltz II Robert C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:36 PM | Arcus Biosciences (Issuer)
Nuyten Dimitry SA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:36 PM | Arcus Biosciences (Issuer)
ROSEN TERRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:36 PM | Arcus Biosciences (Issuer)
Tang Carolyn C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:37 PM | Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
3:23 PM | Arcus Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
3:25 PM | Arcus Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/24/2024
3:11 PM | Arcus Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
10:31 AM | Arcus Biosciences (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
09/17/2024
5:42 PM | Arcus Biosciences (Issuer)
Nuyten Dimitry SA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
5:42 PM | Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
3:12 PM | Arcus Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2024
3:45 PM | Arcus Biosciences (Issuer)
Azoy Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:53 PM | Arcus Biosciences (Issuer)
Tang Carolyn C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:54 PM | Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:54 PM | Arcus Biosciences (Issuer)
Jaen Juan C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:54 PM | Arcus Biosciences (Issuer)
ROSEN TERRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:19 PM | Arcus Biosciences (Issuer)
Lambert Nicole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:20 PM | Arcus Biosciences (Issuer)
Ribas Antoni (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:20 PM | Arcus Biosciences (Issuer)
PERLMAN ANDREW J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:20 PM | Arcus Biosciences (Issuer)
Machado Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:20 PM | Arcus Biosciences (Issuer)
FALBERG KATHRYN E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:20 PM | Arcus Biosciences (Issuer)
Lacey David L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:21 PM | Arcus Biosciences (Issuer)
KANEKO YASUNORI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
We recommended Palantir in 2021, now we’re recommending this... (Ad) I believe it could offer you a MAJOR boost to your retirement.
And it pays huge dividends to give you a nice stream of income along the way. Our research indicates ONE AI stock is poised to benefit the most. |
06/06/2024
3:28 PM | Arcus Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
7:18 AM | Arcus Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2024
3:59 PM | Arcus Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2024
7:21 PM | Arcus Biosciences (Filer)
| Form ARS | |
04/23/2024
3:08 PM | Arcus Biosciences (Filer)
| Form DEF 14A | |
04/23/2024
3:10 PM | Arcus Biosciences (Filer)
| Form DEFA14A | |
03/29/2024
3:20 PM | Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
3:19 PM | Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:30 PM | Arcus Biosciences (Subject)
Jarrett Jennifer (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
6:55 PM | Arcus Biosciences (Issuer)
Jaen Juan C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
6:55 PM | Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:49 PM | Arcus Biosciences (Issuer)
Goeltz II Robert C. (Reporting)
| Form 4/A | |
02/21/2024
3:53 PM | Arcus Biosciences (Filer)
| Form S-3ASR | |
02/21/2024
3:16 PM | Arcus Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
